Immuneering Corp (United States) is listed on the Nasdaq and has a market capitalization of $333.19 million, with shareholders equity totaling $190.74 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Immuneering Corp reported $360.96 Thousand in revenue, generating net income of $-44.21 billion.
Key financial metrics include a P/E ratio of -0.01, a price-to-book (P/B) ratio of 1.75, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker IMRX.